布鲁氏菌
布鲁氏菌病
接种疫苗
毒力
病毒学
怀孕
疾病
生物
布鲁氏菌
减毒疫苗
人畜共患病
医学
免疫学
病理
基因
生物化学
遗传学
作者
Martha E. Hensel,Daniel G. García-González,Sankar P. Chaki,Airn E. Hartwig,Paul Gordy,Richard A. Bowen,Thomas A. Ficht,Angela M. Arenas‐Gamboa
出处
期刊:mSphere
[American Society for Microbiology]
日期:2020-06-24
卷期号:5 (3)
被引量:17
标识
DOI:10.1128/msphere.00120-20
摘要
Brucellosis is one of the most commonly reported zoonotic disease with a worldwide distribution. Of the 12 Brucella species, Brucella melitensis is considered the most virulent and causes reproductive failure (abortions/stillbirths) in small ruminants, which can spread the disease to other animals or to humans. Vaccination of small ruminants is a key measure used to protect both human and animal health. However, the commercially available live-attenuated vaccine for Brucella melitensis Rev. 1 retains virulence and can cause disease in animals and humans. In order to evaluate the safety and efficacy in sheep, we vaccinated pregnant sheep with 16M ΔvjbR . Our results indicate that 16M ΔvjbR was safer for use during pregnancy, provided a similar level of protection as Rev. 1, and could be considered an improved candidate for future vaccine trials.
科研通智能强力驱动
Strongly Powered by AbleSci AI